×
Close
註冊
登入
主页
医学图书S馆
医学图书D馆
活动
Upcoming Events
Past Events
用户工具
用户指南
语言
English
中文/ Chinese
French
Português
Español
Arabic
Russian
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
分类
Hematology
5456
Global Medical University
5020
Allergy
1783
Anatomy & Morphology
1527
Andrology
414
Anesthesia & Intensive Care
1214
Anesthesiology
5442
Audiology & Speech-Language Pathology
332
Behavioral Sciences
100
Biochemical Research Methods
6818
Biochemistry & Molecular Biology
29335
Biodiversity Conservation
288
Biology
8218
Biophysics
8099
Biotechnology & Applied Microbiology
8197
Cardiac & Cardiovascular Systems
30752
Cardiovascular & Respiratory Systems
1391
Cell & Tissue Engineering
654
Cell Biology
10825
Chemistry, Analytical
4216
Chemistry, Applied
11003
Chemistry, Medicinal
8487
Chemistry, Multidisciplinary
18503
Clinical Immunology & Infectious Disease
442
Clinical Medicine
8751
Clinical Neurology
16238
Clinical Psychology & Psychiatry
1298
Critical Care Medicine
3153
Dentistry, Oral Surgery & Medicine
12959
Dermatology
7601
Developmental Biology
6915
Ecology
645
Education, Scientific Disciplines
1886
Emergency Medicine
3981
Endocrinology, Metabolism & Nutrition
23582
Engineering, Biomedical
3586
Entomology
425
Environmental Medicine & Public Health
4623
Evolutionary Biology
254
Gastroenterology & Hepatology
11883
General & Internal Medicine
6948
Genetics & Heredity
14711
Geriatrics & Gerontology
5022
Gerontology
338
Health Care Sciences & Services
15636
Health Policy & Services
594
Immunology
24666
Infectious Diseases
13671
Integrative & Complementary Medicine
2758
Medical Ethics
1146
Medical Informatics
2117
Medical Laboratory Technology
433
Medicine, General & Internal
44233
Medicine, Legal
493
Medicine, Research & Experimental
17436
Microbiology
22778
Mycology
0
Nanoscience & Nanotechnology
5039
Neuroimaging
1293
Neurology
4396
Neurosciences
38942
Nursing
9355
Nutrition & Dietetics
7802
Obstetrics & Gynecology
8102
Oncology
51594
Ophthalmology
9493
Optics
4025
Orthopedics
11367
Orthopedics, Rehabilitation & Sports Medicine
1729
Otolaryngology
1505
Otorhinolaryngology
4791
Parasitology
1040
Pathology
4888
Pediatrics
21065
Peripheral Vascular Disease
4693
Pharmacology & Pharmacy
33972
Pharmacology/Toxicology
12027
Physiology
8875
Polymer Science
539
Primary Health Care
815
Psychiatry
18891
Psychology
5053
Psychology, Applied
92
Psychology, Biological
335
Psychology, Clinical
785
Psychology, Developmental
222
Psychology, Educational
149
Psychology, Experimental
122
Psychology, Mathematical
0
Psychology, Multidisciplinary
1590
Psychology, Psychoanalysis
41
Psychology, Social
114
Public Health & Health Care Science
2227
Public, Environmental & Occupational Health
26926
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12032
Radiology, Nuclear Medicine & Medical Imaging
7772
Rehabilitation
2967
Remote Sensing
0
Reproductive Biology
2745
Reproductive Medicine
1131
Research/Laboratory Medicine & Medical Technology
3872
Respiratory System
7101
Rheumatology
5751
Social Sciences, Biomedical
1176
Substance Abuse
2676
Surgery
33275
Toxicology
4241
Transplantation
927
Tropical Medicine
314
Urology & Nephrology
12745
Veterinary Sciences
35
Virology
2383
Zoology
0
渠道
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
Hematology\Oncology
3
Medrxiv - Hematology
184
AMERICAN JOURNAL OF HEMATOLOGY
248
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BLOOD CANCER JOURNAL
448
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
383
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
532
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
141
BLOOD COAGULATION & FIBRINOLYSIS
66
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
41
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
224
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
176
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
404
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
107
INTERNATIONAL JOURNAL OF HEMATOLOGY
543
JOURNAL OF HEMATOPATHOLOGY
121
SCI时时刷
search
全部
推荐
+
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study
Background:COVID-19 patients present with both elevated D-dimer and a higher incidence of pulmonary embolism (PE). This si...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prophylactic management of patients with von Willebrand disease
Von Willebrand disease, the most common inherited bleeding disorder that affects both males and females, is due to quantit...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
Introduction:Treatment-refractory, acute graft-versus-host disease (GvHD) of the lower gastrointestinal tract (GI) after a...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
Mitapivat (AG-348) is a novel, first-in-class oral small molecule allosteric activator of the pyruvate kinase enzyme. Mita...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy
Inotuzumab ozogamicin (INO) showed improved treatment outcomes for relapsed or refractory B-cell precursor acute lymphobla...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
Background:Allogeneic stem cell transplantation (alloSCT) offers cure chance for various hematologic malignancies, but gra...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
Introduction:The choice of BCR-ABL1 tyrosine kinase inhibitors (TKI) for the first line of therapy (LOT) for chronic-phase...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
Primary systemic immunoglobulin light chain (AL) amyloidosis is caused by a plasma cell clone of, usually low, malignant p...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Bortezomib in autoimmune hemolytic anemia and beyond
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multip...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
1. Rodriguez-Abreu, D, Bordoni, A, Zucca, E. Epidemiology of hematological malignancies. Ann Oncol 2007; 18(Suppl. 1): i3–...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
Introduction:In patients with primary immune thrombocytopenia (ITP), a short course of steroids is routinely given as firs...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Current and emerging treatment options in primary mediastinal B-cell lymphoma
Previously considered a subtype of diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL) is n...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Case series: MRD negativity assessment using 11C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma
Complete response (CR) is an important favorable factor for survival in multiple myeloma (MM). However, CR patients contin...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)
Background:Inhibitor development is the most serious treatment-related complication of replacement coagulation factor VIII...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome
Introduction:Donor lymphocyte infusion (DLI) is one of the effective options for post-transplant disease control of myelod...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Emicizumab in acquired haemophilia A: about two clinical cases and literature review
Acquired haemophilia A (AHA) is a rare and severe haemorrhagic autoimmune disease caused by autoantibodies directed agains...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
The pathological increase of clonal IgM in Waldenström macroglobulinemia can be associated with acquired von Willebrand sy...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report
A man with severe hemophilia A (HA) without factor VIII (FVIII) inhibitors was admitted for total arthroplasty of his elbo...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review
The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplan...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
Background:Daratumumab (Dara) is generally well tolerated, but is associated with increased risk of infection.Methods:We i...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data
Background:DDX41 serves as a DNA sensor in innate immunity and mutated DDX41 is pathogenic, mainly for myeloid neoplasms.M...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The use of tafasitamab in diffuse large B-cell lymphoma
Patients who relapse or are refractory after first-line therapy for diffuse large B-cell lymphoma (DLBCL) frequently have ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies
Background and aims:The application of QuantiFERON-TB Gold in-Tube (QFT-GIT) in patients with haematological malignancies ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma
Aims:This study quantifies the value of survival gains attributable to novel treatments approved since 2003 for United Sta...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Treosulfan-based conditioning for inborn errors of immunity
Inborn errors of immunity (IEI) are inherited disorders that lead to defects in the development and/or function of the imm...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
Diffuse large B-cell lymphoma (DLBCL) represents a group of tumors characterized by substantial heterogeneity in terms of ...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of tazemetostat in relapsed/refractory follicular lymphoma
Large strides have been made in the treatment of follicular lymphoma (FL) over the last few years. Although the majority o...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma
Chimeric antigen receptor (CAR) T-cell therapy with axicabtagene ciloleucel (axi-cel) continues to make its way in the tre...
Therapeutic Advances In Hematology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin